您当前的位置:洛度沙胺氨丁三醇

洛度沙胺氨丁三醇

时间:2023-07-15  来源:化工号   作者:C11H6ClN3O6.2C4H11NO3
  • 洛度沙胺氨丁三醇
  • 2-氨基-2-(羟甲基)丙烷-1,3-二醇 半(2,2'-((2-氯-5-氰基-1,3-亚苯基)双(氮烷二基))双(2-氧代乙酸盐) )
  • 中文名 洛度沙胺氨丁三醇
    英文名 Lodoxamide tromethamine
    别名 洛度沙胺氨丁三醇
    2-氨基-2-(羟甲基)丙烷-1,3-二醇 半(2,2'-((2-氯-5-氰基-1,3-亚苯基)双(氮烷二基))双(2-氧代乙酸盐) )
    英文别名 AlMide
    AloMide
    U-42585-E
    LodoxaMide troMetaMol
    Lodoxamidetromethamine
    Lodoxamide tromethamine
    LodoxaMide troMethaMineon
    LodoxaMide troMethaMine salt
    Lodoxamide tromethamine (U 42585 E)
    CAS 63610-09-3
    化学式 C11H6ClN3O6.2C4H11NO3
    分子量 553.906
    存储条件 under inert gas (nitrogen or Argon) at 2–8 °C
    体外研究 lodoxamide inhibits compound 48/80-induced histamine release and ionophore-induced 45 Ca influx with associated histamine release in purified rat peritoneal mast cells.
    体内研究 Lodoxamide has been demonstrated to have cromolyn-like activity when studied in the rat peritoneal mast cell assay (PCA) model3 and in Ascaris antigen-sensitized rhesus monkeys. When given intravenously, orally, or intrabronchially by aerosol, lodoxamide significantly inhibits the increased respiratory frequency and decreased tidal volume induced by antigen challenge in Ascaris-sensitized. anesthetized rhesus monkeys. Addition of lodoxamide tromethamine to Euro-Collins or University of Wisconsin solution results in a marked decrease in lung reperfusion injury as demonstrated by increased oxygenation, decreased microvascular permeability, and increased compliance. Patients treated with lodoxamide tromethamine demonstrate an improvement in daytime breathing difficulty, cough, sputum production, and sleep.
    来顶一下
    返回首页
    返回首页
    推荐资讯
    热门点击